Celsion CORP Sample Contracts
PREFUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK Imunon, INC.Security Agreement • May 27th, 2025 • Imunon, Inc. • Pharmaceutical preparations
THIS PREFUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK (the “Warrant”) certifies that, for value received, _____ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Imunon, Inc., a Delaware corporation (the “Company”), up to ___ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES DDD COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • November 14th, 2017 • Celsion CORP • Pharmaceutical preparations
THIS SERIES DDD COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ ], 2018 (the “Initial Exercise Date”) and on or prior to the close of business on [ ], 2019 (the “Termination Date”, provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day) but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 19th, 2025 • Imunon, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of [●], 2025, between Imunon, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
andRights Agreement • August 21st, 2002 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 27th, 2025 • Imunon, Inc. • Pharmaceutical preparations
SECTION 1 - DEFINITIONSLicense Agreement • December 13th, 1996 • Cheung Laboratories Inc • Electromedical & electrotherapeutic apparatus • New York
AMENDMENT NO. 1 TO RIGHTS AGREEMENT DATED AS OF AUGUST 15, 2002Rights Agreement • June 14th, 2004 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
EXHIBIT 10.24 SERVICE AGREEMENT ----------------- This Agreement, made and entered into this 20th day of September 2000, between the British Columbia Cancer Agency, Division of Medical Oncology, Investigational Drug Section's ProPharma Pharmaceutical...Service Agreement • December 28th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus • British Columbia
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT, effective as of the 8th day of June, 2000, by and between John Mon (the "Executive"), an individual residing at c/o Celsion Corporation, 10220-1 Old...Executive Employment Agreement • December 30th, 2002 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
M.H. MEYERSON & CO., INC. FOUNDED 1960 BROKER & DEALER IN SECURITIES UNDERWRITERSAgreement • July 6th, 2001 • Celsion Corp • Electromedical & electrotherapeutic apparatus • New Jersey
301650.001(BF) 1Consulting Agreement • December 12th, 1996 • Cheung Laboratories Inc • Electromedical & electrotherapeutic apparatus • Illinois
Form of Registration Rights Agreement THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made by Celsion Corporation, a Maryland corporation (the "Company"), for the benefit of the undersigned investor (the "Investor"; collectively, the...Registration Rights Agreement • January 13th, 1999 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 27th, 2025 • Imunon, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 23, 2025, between Imunon, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made by Cheung Laboratories, Inc., a Maryland corporation (the "Company"), for the benefit of the undersigned investor ("Investor", collectively, the "Investors")....Registration Rights Agreement • January 13th, 1999 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
EXHIBIT 10.24 ADVISORY AGREEMENT THIS ADVISORY AGREEMENT (the "Agreement") is effective as of the 18th day of May, 2001, by and between CELSION CORPORATION, a Delaware corporation (the "Company"), and DR. KRIS VENKAT ("Venkat"), and SUNDARI...Advisory Agreement • December 28th, 2001 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
AMENDMENT NO. 1 TO RIGHTS AGREEMENT DATED AS OF AUGUST 15, 2002Rights Agreement • June 14th, 2004 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
WITNESSETH:Executive Employment Agreement • December 28th, 2001 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
CELSION CORPORATION Up to $25,000,000 of Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • February 1st, 2013 • Celsion CORP • Pharmaceutical preparations • New York
Celsion Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
WARRANT TO PURCHASE SHARES OF COMMON STOCK Imunon, INC.Warrant Agreement • May 27th, 2025 • Imunon, Inc. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE SHARES OF COMMON STOCK (the “Warrant”) certifies that, for value received, _____ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the three (3) year anniversary of the Initial Exercise Date, provided that, if such date is not a Trading Day, the date that is the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from Imunon, Inc., a Delaware corporation (the “Company”), up to ___ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXHIBIT 4.14 CONSULTING AGREEMENT -------------------- THIS CONSULTING AGREEMENT (this "Agreement") is made and entered into by and between CELSION CORPORATION, a Delaware Corporation, which has an address of 10220-I Old Columbia Road, Columbia,...Consulting Agreement • June 14th, 2004 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
EXHIBIT 10.9 LICENSE AGREEMENT THIS AGREEMENT made and entered into as of the tenth day of November, 1999 (this "AGREEMENT"), by and between DUKE UNIVERSITY, a North Carolina not-for-profit corporation organized under the laws of North Carolina (the...License Agreement • December 29th, 1999 • Celsion Corp • Electromedical & electrotherapeutic apparatus • North Carolina
COMMON STOCK PURCHASE WARRANT Celsion CorporationCommon Stock Purchase Warrant • March 13th, 2020 • Celsion CORP • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 10, 2020 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 10, 2025 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to [__________] shares of common stock, par value $0.01 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 10.1 ------------ EXECUTIVE EMPLOYMENT AGREEMENT ------------------------------ EMPLOYMENT AGREEMENT, made as of the 14th day of January, 2000, by and between Spencer J. Volk (the "Executive"), an individual residing at c/o Celsion...Executive Employment Agreement • February 24th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus
WITNESSETH:Executive Employment Agreement • December 14th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
COMMON STOCK PURCHASE WARRANT CELSION CORPORATIONCommon Stock Purchase Warrant • February 26th, 2013 • Celsion CORP • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXHIBIT 10.1 LICENSE AGREEMENT THIS AGREEMENT made and entered into this eighteenth day of July, 2003, by and between DUKE UNIVERSITY, a North Carolina corporation not-for-profit, (hereinafter called the "LICENSOR"), having its principal office at...License Agreement • August 28th, 2003 • Celsion Corp • Electromedical & electrotherapeutic apparatus • North Carolina
RECITALSLetter of Intent • December 13th, 1996 • Cheung Laboratories Inc • Electromedical & electrotherapeutic apparatus • Maryland
November 25,1997 Dr. Fred Sterzer, President MMTC, Inc. 12 Roszel Road, Suite A-203 Princeton, NJ 08540 RE: Amendment to the License Agreement between MMTC, Inc. ("MMTC ") and Cheung Laboratories, Inc. ("CLI") dated August 23, 1996 as extended April...License Agreement • December 2nd, 1999 • Celsion Corp • Electromedical & electrotherapeutic apparatus
EXHIBIT 10.23 OPTION AGREEMENT ---------------- This AGREEMENT is made this 8th day of August, 2000, between Duke University (hereinafter referred to as "University"), a university having an office at Durham, North Carolina, and Celsion Corporation...Option Agreement • December 28th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus • North Carolina
and CHEUNG LABORATORIES, INC. PATENT LICENSE AGREEMENT M.I.T.'S OFFER TO CHEUNG LABORATORIES, INC. TO ENTER INTO THIS LICENSE AGREEMENT SHALL EXTEND UNTIL NO LATER THAN OCTOBER 31, 1997 ---------------- (EXCLUSIVE) iPatent License Agreement • December 2nd, 1999 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Massachusetts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 7th, 2022 • Celsion CORP • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 6, 2022, between Celsion Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PURCHASE AGREEMENTPurchase Agreement • September 8th, 2020 • Celsion CORP • Pharmaceutical preparations • Illinois
THIS PURCHASE AGREEMENT (the “Agreement”), dated as of September 8, 2020, by and between CELSION CORPORATION, a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). Capitalized terms used herein and not otherwise defined herein are defined in Section 1 hereof.
AGREEMENT ---------Retirement Agreement • August 28th, 2003 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
BETWEENTransaction Agreement • January 22nd, 2003 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
Celsion CorporationPlacement Agent Agreement • April 7th, 2022 • Celsion CORP • Pharmaceutical preparations • New York